In addition, microarray data from CD34-positive cells isolated from peripheral blood showed increased levels of TGFβ and TGFβ receptor 1 (TGFBR1) mRNA in MPN patients compared to HDs22 (Supplementary Fig. 2a). This evidence concerns the gene TGFBR1 and myeloproliferative disorder.